Literature DB >> 21671728

The adaptation of human embryonic stem cells to different feeder-free culture conditions is accompanied by a mitochondrial response.

Verónica Ramos-Mejia1, Clara Bueno, Mar Roldan, Laura Sanchez, Gertrudis Ligero, Pablo Menendez, Miguel Martin.   

Abstract

The mitochondrial contribution to the maintenance of human embryonic stem cell (hESC) pluripotency and culture homeostasis remains poorly understood. Here, we sought to determine whether hESC adaptation to different feeder-free culture conditions is linked to a mitochondrial adaptation. The expression of ESC pluripotency factors and parameters of mitochondrial contribution including mitochondrial membrane potential, mtDNA content, and the expression of master mitochondrial genes implicated in replication, transcription, and biogenesis were determined in 8 hESC lines maintained in 2 distinct human feeders-conditioned media (CM): human foreskin fibroblast-CM (HFF-CM) and mesenchymal stem cell-CM (MSC-CM). We show a robust parallel trend between the expression of ESC pluripotency factors and the mitochondrial contribution depending on the culture conditions employed to maintain the hESCs, with those in MSC-CM consistently displaying increased levels of pluripotency markers associated to an enhanced mitochondrial contribution. The differences in the mitochondrial status between hESCs maintained in MSC-CM versus HFF-CM respond to coordinated changes in mitochondrial gene expression and biogenesis. Importantly, the culture conditions determine the mitochondrial distribution within the stage-specific embryonic antigen 3 positive (SSEA3(+)) and negative (SSEA3(-)) isolated cell subsets. hESC colonies in MSC-CM display an "intrinsic" high mitochondrial status which may suffice to support undifferentiated growth, whereas hESC colonies maintained in HFF-CM show low mitochondrial status, possibly relying on the production of autologous niche with higher mitochondrial status to support pluripotency and culture homeostasis. Pluripotency markers and mitochondrial status are concomitantly reverted on changing the culture conditions, supporting an unrecognized role of the mitochondria in response to hESC culture adaptation. We provide the first evidence supporting that hESCs adaptation to different feeder-free culture systems relies on a mitochondrial response.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21671728     DOI: 10.1089/scd.2011.0248

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  14 in total

1.  Cord blood-derived CD34+ hematopoietic cells with low mitochondrial mass are enriched in hematopoietic repopulating stem cell function.

Authors:  Damia Romero-Moya; Clara Bueno; Rosa Montes; Oscar Navarro-Montero; Francisco J Iborra; Luis Carlos López; Miguel Martin; Pablo Menendez
Journal:  Haematologica       Date:  2013-01-24       Impact factor: 9.941

2.  Mitochondrial metabolism directs stemness and differentiation in P19 embryonal carcinoma stem cells.

Authors:  I Vega-Naredo; R Loureiro; K A Mesquita; I A Barbosa; L C Tavares; A F Branco; J R Erickson; J Holy; E L Perkins; R A Carvalho; P J Oliveira
Journal:  Cell Death Differ       Date:  2014-05-16       Impact factor: 15.828

3.  Defined culture of human embryonic stem cells and xeno-free derivation of retinal pigmented epithelial cells on a novel, synthetic substrate.

Authors:  Britney O Pennington; Dennis O Clegg; Zara K Melkoumian; Sherry T Hikita
Journal:  Stem Cells Transl Med       Date:  2015-01-15       Impact factor: 6.940

4.  Mitochondrial-associated cell death mechanisms are reset to an embryonic-like state in aged donor-derived iPS cells harboring chromosomal aberrations.

Authors:  Alessandro Prigione; Amir M Hossini; Björn Lichtner; Akdes Serin; Beatrix Fauler; Matthias Megges; Rudi Lurz; Hans Lehrach; Eugenia Makrantonaki; Christos C Zouboulis; James Adjaye
Journal:  PLoS One       Date:  2011-11-14       Impact factor: 3.240

5.  The secretome of stem cells isolated from the adipose tissue and Wharton jelly acts differently on central nervous system derived cell populations.

Authors:  Carlos A Ribeiro; Joana S Fraga; Mário Grãos; Nuno M Neves; Rui L Reis; Jeffrey M Gimble; Nuno Sousa; António J Salgado
Journal:  Stem Cell Res Ther       Date:  2012-05-02       Impact factor: 6.832

6.  Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors.

Authors:  Verónica Ramos-Mejía; Rosa Montes; Clara Bueno; Verónica Ayllón; Pedro J Real; René Rodríguez; Pablo Menendez
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

7.  Characterisation of mesothelioma-initiating cells and their susceptibility to anti-cancer agents.

Authors:  Elham Alizadeh Pasdar; Michael Smits; Michael Stapelberg; Martina Bajzikova; Marina Stantic; Jacob Goodwin; Bing Yan; Jan Stursa; Jaromira Kovarova; Karishma Sachaphibulkij; Ayenachew Bezawork-Geleta; Margaryta Sobol; Anatoly Filimonenko; Marco Tomasetti; Renata Zobalova; Pavel Hozak; Lan-Feng Dong; Jiri Neuzil
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

8.  Identification of Cdca7 as a novel Notch transcriptional target involved in hematopoietic stem cell emergence.

Authors:  Jordi Guiu; Dylan J M Bergen; Emma De Pater; Abul B M M K Islam; Verónica Ayllón; Leonor Gama-Norton; Cristina Ruiz-Herguido; Jessica González; Nuria López-Bigas; Pablo Menendez; Elaine Dzierzak; Lluis Espinosa; Anna Bigas
Journal:  J Exp Med       Date:  2014-11-10       Impact factor: 14.307

Review 9.  Defining synthetic surfaces for human pluripotent stem cell culture.

Authors:  Jack W Lambshead; Laurence Meagher; Carmel O'Brien; Andrew L Laslett
Journal:  Cell Regen (Lond)       Date:  2013-11-22

10.  hESC expansion and stemness are independent of connexin forty-three-mediated intercellular communication between hESCs and hASC feeder cells.

Authors:  Jin-Su Kim; Daekee Kwon; Seung-Taeh Hwang; Dong Ryul Lee; Sung Han Shim; Hee-Chun Kim; Hansoo Park; Won Kim; Myung-Kwan Han; Soo-Hong Lee
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.